Microdomain disruption via cholesterol depletion decreased Saquinavir affinity for Pglycoprotein, potentially implicating these structures in the influence of α-tocopherol succinate on P-glycoprotein. This study provides evidence of a microdomain dipole potential-dependent mechanism by which α-tocopherol analogues influence P-glycoprotein activity. These findings have implications for the use of α-tocopherol derivatives for drug delivery across biological barriers.
Introduction
The plasma membrane of mammalian cells has diverse functions, many of which are impaired by oxidative damage to its constituent lipids and proteins. The effects of such damage are seen in conditions ranging from natural ageing to type II diabetes as well as specific diseases of the nervous and cardiovascular systems [1] [2] [3] [4] . It is not surprising therefore, that antioxidants such as vitamin E have attracted considerable attention as potential protective or palliative agents. In vitro, vitamin E has been widely demonstrated as having a free-radical scavenging antioxidant action [5] . However, its mechanism of action in vivo remains controversial [6, 7] as treatment with vitamin E has yielded negligible benefit against oxidative stress and in some instances has resulted in cytotoxic effects [8] [9] [10] [11] . In the present report we demonstrate that vitamin E has the capability to modify the membrane dipole potential. We also show evidence that tocopheroldependent changes of the membrane dipole potential can lead to changes of the ligand binding capability of the multi-drug efflux pump P-glycoprotein (P-gp). Such observations suggest therefore, that it is worth considering that some of the reported effects of tocopherols may arise through such mechanisms [as outlined in [12] ] rather than resulting solely from anti-oxidant properties.
α-Tocopherol is the form of vitamin E most preferentially absorbed by the human body [13] despite the β-, γ-and δ-isoforms, and the tocotrienol counterparts, also exhibiting free radical scavenging action in vitro [14] . This observation, along with other evidence, supports the argument that α-tocopherol must have significant non-antioxidant roles not shared by other antioxidants [6] prompting investigations to identify the non-antioxidant physiological effects of α-tocopherol. α-Tocopherol succinate has received attention as an analogue of α-tocopherol that demonstrates no in vitro free-radical scavenging action [15] but is reported to possess clinically relevant effects, such as improving the efficacy of chemotherapy when administered by guest, on October 30, 2017 www.jlr.org Downloaded from 4 as a co-therapeutic agent [16, 17] . This effect is likely to involve the multi-drug efflux pump Pgp, but the underlying mechanism responsible is not well understood.
Both α-tocopherol and its succinate ester analogue, the structures of which are shown in Fig. 1 , are reported to have a number of effects on model biological membranes. These include imparting a negative curvature stress [18] and modifying the phase behaviour of lipids; decreasing the enthalpy of the gel to liquid crystalline transition by influencing lipid organisation [19, 20] and inducing phase separation as a result of preferential association with specific lipids [21, 22] . The present study investigates the effect of α-tocopherol and α-tocopherol succinate on the membrane dipole potential, which is both a sensitive indicator of changes in lipid organisation and that of surrounding water molecules [12, [23] [24] [25] [26] [27] [28] , and directly influences the behaviour of membrane proteins [25, 29, 30 ].
We utilise fluorescent probes developed in our laboratories as sensitive indicators of molecular interactions with membranes [30] . The first, Fluorescein-phosphatidylethanolamine (FPE) is an indicator of the electrostatic surface potential and so reports the addition or loss of electrical charge to the membrane surface. The second membrane localised fluorescent probe, Di-8-ANEPPS, reports the level of the membrane dipole potential and its use as an indicator of molecular interactions is described in refs [12, 25, 29, 30] . The virtue of both these indicators is that they can be used in exactly the same fashion in model membrane systems as in living cell membranes [e.g. [29] ]. We use these techniques to show that in intact cells both α-tocopherol succinate and oxidised cholesterol, 7-ketocholesterol, decrease the dipole potential and influence the interaction of the Saquinavir with P-glycoprotein. 
Materials and Methods

Reagents
D-α-tocopherol, D-α-tocopherol succinate, cholesterol, 7-ketocholesterol and methyl-β-cyclodextrin were supplied by Sigma Aldrich (UK). Egg-phosphatidylcholine (PC) was supplied by Lipid Products (UK). Saquinavir was supplied by Roche (UK). Di-8-ANEPPS ((1-
were obtained from Invitrogen (UK). Cell culture reagents including RPMI 1640, Dulbecco's phosphate buffered saline (DPBS), foetal bovine serum (FBS), penicillin-streptomycin mixture, L-glutamine and Trypan Blue (0.4% solution) were obtained from Sigma Aldrich (UK). All other reagents were also supplied by Sigma Aldrich (UK) at the highest purity available.
Model membrane vesicle preparation and labelling with Di-8-ANEPPS
Large unilamellar phosphatidylcholine vesicles were prepared and labelled with Di-8-ANEPPS as described in ref [29] . Briefly, egg-phosphatidylcholine (PC), D-α-tocopherol, D-α-tocopherol succinate, cholesterol and 7-ketocholesterol dissolved in 5:1 chloroform:methanol were combined at the desired proportions and the solvent evaporated by gentle rotation under a stream of oxygen-free nitrogen gas. The resulting lipid film was rehydrated with 280 mM sucrose, 10 mM tris, pH 7.4, and this multilamellar solution was then subject to five freezethaw cycles in liquid nitrogen to promote the formation of unilamellar vesicles. Finally, the vesicles were extruded ten times through polycarbonate filters with 100 nm pores (Nucleopore After this time cells were washed twice in DPBS by centrifugation (300 g, 5 min) to remove unbound FPE and resuspended at 0.5x10 6 cells ml -1 in 280 mM sucrose, 10 mM tris, pH 7.4.
Depletion of cell membrane cholesterol
Methyl-β-cyclodextrin was used to remove cholesterol from the plasma membrane of cells using a method adapted from [33] reported to result in the removal of most of the cholesterol from membrane microdomains (rafts) with negligible effects on cell viability. Following labelling with Di-8-ANEPPS or FPE, cells were washed twice in DPBS by centrifugation (300 g, 5 min) before exposure to 10 mM methyl-β-cyclodextrin in 280 mM sucrose, 10 mM tris, pH 7 7.4, for 1 min. Cells were then immediately centrifuged (500 g, 2 min) and resuspended in fresh 280 mM sucrose, 10 mM tris, pH 7.4.
Cell viability
An alamarBlue resazurin reduction assay (Invitrogen, Carlsbad, CA, USA) was used to assess cell viability and was performed according to the manufacturer's instructions. After incubating cells with α-tocopherol succinate, cholesterol or 7-ketocholesterol at the maximum concentration and for the maximum exposure time relevant to this study, 10% v/v alamarBlue was added to the cells in a 96 well plate. After a 4 hr incubation at 37 o C with 5% CO 2 fluorescent measurements were made at 590 nm with 550 nm excitation using a LS-55 plate reader (Perkin Elmer, MA, USA). Baseline readings were taken from culture medium and alamarBlue reagent without cells.
Fluorescence Spectroscopy Measurements
The spectral sensitivity of membrane bound Di-8-ANEPPS to the dipole potential was used to determine relative differences in the dipole potential of phospholipid vesicles of varying composition and the relative changes in the dipole potential on the interaction of exogenously 
Results
Modulation of the membrane dipole potential by α-tocopherol and α-tocopherol succinate -The
influence of α-tocopherol and α-tocopherol succinate on the membrane dipole potential was first explored in a lipid vesicle membrane system. Egg phosphatidylcholine (PC) vesicles containing α-tocopherol or its analogue α-tocopherol succinate were prepared using lipid film hydration followed by extrusion [31] . The change in the membrane dipole potential due to the incorporation of these forms of vitamin E was observed by the potential-dependant shift in the excitation spectrum of the electrochromic fluorescent probe Di-8-ANEPPS [12] . Following 7-ketocholesterol treatment the Hill coefficient (see Table 1 ) of the sigmoidal binding profile, reflecting the extent of cooperativity in the interaction, is not significantly altered (unpaired two-tailed t test; P = 0.42). Following treatment with α-tocopherol succinate, however, the Hill coefficient is significantly reduced (unpaired two tailed t-test; P = 0.02, R 2 = 0.75). This observation suggests that α-tocopherol succinate is exerting a significant effect on the nature of the Saquinavir-P-gp binding mechanism that is not induced by 7-ketocholesterol.
The mechanism underlying the cooperative nature of the Saquinavir-P-gp interaction is unknown, however, the activity of P-gp is thought to be membrane microdomain-associated (Figure 3 , Table 1 ),
suggesting the activity of P-gp is membrane microdomain-dependant. The Hill coefficient for the interaction (see Table 1 ) was also much reduced suggesting cholesterol-rich microdomains may have an important role in the underlying mechanism of the Saquinavir-P-gp interaction.
Interestingly, the effect of methyl-β-cyclodextrin and α-tocopherol succinate on the cooperativity of the Saquinavir-P-gp interaction are similar (unpaired two tailed t-test on Hill coefficients; P = 0.09). We suggest that α-tocopherol succinate influences P-gp by decreasing the dipole potential of P-gp that is associated with membrane microdomains. 
Discussion
The present study demonstrates that the interaction of α-tocopherol and its water soluble derivative, α-tocopherol succinate, with biological membranes leads to changes of the membrane dipole potential. A schematic representation of these interactions and their effects in relation to those of cholesterol is shown in Fig. 5 . As α-tocopherol succinate is a non-free radical scavenging analogue of α-tocopherol, this effect is independent of, and may be additional to, any free radical scavenging activity for α-tocopherol.
Supplementing membranes with α-tocopherol succinate appears to influence the interaction of the anti-retroviral agent Saquinavir most likely through effects on the multi-drug efflux pump, P-gp. This membrane receptor is reported to be sensitive to change in the dipole potential [29] and its activity is linked here and elsewhere [29, 38, 39] with cholesterol-rich membrane microdomains. α-Tocopherol succinate is shown to have a preferential affinity for membranes rich in these microdomains suggesting its possible localisation within these structures. While direct evidence for the association of tocopherol succinate with cholesterol enriched membrane microdomains remains elusive, this hypothesis is supported by previous observations that the membrane localisation of tocopherol succinate influences the activity of microdomainassociated kinases, including protein kinase C [40, 41] . In the present study, the membrane interactions of tocopherol succinate were also shown to influence the nature of the Saquinavir-P-gp interaction with similar effect to microdomain disruption via membrane cholesterol depletion. We hypothesize that the mechanism by which α-tocopherol succinate influences Pgp is via its effect to decrease the dipole potential of membrane microdomains with which this receptor associates. In support of this notion, 7-ketocholesterol, an oxidised form of cholesterol known to localise in cholesterol-rich microdomains [42, 43] and demonstrated to decrease the dipole potential of the plasma membrane, was also shown to influence the interaction of Saquinavir with P-gp. The apparent differences in the extent to which α-tocopherol succinate The implications of α-tocopherol succinate modulation of P-gp activity are significant. The cytotoxicity of many native and xenobiotic compounds could be increased due to the reduced ability of P-gp to remove them from the cell. In addition to the potential negative side effects this may cause, α-tocopherol succinate treatment may increase the efficacy of applied therapeutic agents by improved cellular retention. In addition, α-tocopherol succinate may also have a role in countering multi-drug resistance. This phenomenon is associated with P-gp which is able to remove a wide variety of chemically unrelated drugs from cells including antibiotics, anti-cancer agents and anti-HIV agents such as Saquinavir [44] [45] [46] . For example, increased expression of P-gp is observed in some cancerous tumour cells [47] and the consequent increase in drug resistance is associated with the failure of chemotherapy [45, 46] .
Interestingly, α-tocopherol succinate treatment has been shown to increase the efficacy of some chemotherapeutic agents [16, 17] and this effect could be explained therefore, by a similar mechanism to that proposed in our present work.
Drug delivery across biological barriers is presently considered a major bottle-neck for the delivery of therapeutics to target tissues [48] . Multidrug resistance (MDR) transporters such as P-gp (MDR1) play an important role in maintaining epithelial and endothelial barrier function by actively transporting a wide variety of predominantly small hydrophobic xenobiotics and toxins out of cells [49] . P-gp is expressed in multiple biological barriers including the blood- brain [50] , blood-retinal [51] , corneal [52] and intestinal mucosal barriers [53] . In addition, over expression of this protein has also long been known to play a central role in the development of multi-drug resistant cancer [54] . Inhibitors of P-gp, are well documented to improve drug delivery across biological barriers [55, 56] , enhance bioavailability of orally administered therapeutics [57] and overcome multi-drug resistant cancers [58] . For these reason there has been considerable interest in the development of well tolerated P-gp inhibitors [49] .
For example, α-tocopherol polyethylene glycol succinate is reported to enhance oral absorption of several therapeutic compounds, including Cyclosporin, Paclitaxel, Doxorubicin, Vinblastine and Colchicine, through P-gp inhibition [44, 59] . This PEGylated α-tocopherol succinate is likely to influence the dipole potential in a similar manner to α-tocopherol and its nonPEGylated succinate ester and modulate P-gp activity via the same mechanism.
The dipole potential is a determinant of the functions of various membrane proteins in addition to the P-gp investigated in the present study, and many proteins have been identified as being present in membrane microdomains. Our observations may therefore apply to a variety of proteins and different cell types. α-Tocopherol, through its localisation in membrane microdomains [43] , may influence the function of microdomain-associated proteins via the same mechanism we propose for α-tocopherol succinate. Indeed the ubiquity of this mechanism may help to explain the diverse and, sometimes apparently contradictory, actions which have been ascribed to vitamin E.
In conclusion, the present study demonstrates that α-tocopherol and α-tocopherol succinate modulate the dipole potential of artificial and cell membranes. This effect may contribute towards an explanation of the diverse physiological actions of Vitamin E. In addition, this effect forms the basis of a mechanism for the indirect inhibition of P-gp by α-tocopherol Figure 3 for the interaction of Saquinavir with T-lymphocytes, either untreated or pre-treated with 7-ketocholesterol (7-KC), α-tocopherol succinate (α-TS) or methyl-β-cyclodextrin (MβCD). Figure 1 by guest, on October 30, 2017
